Standout Papers

Systemic pharmacokinetics following intravitreal injections of ranibizumab, bevacizumab or afliberc... 2014 2026 2018 2022 274
  1. Systemic pharmacokinetics following intravitreal injections of ranibizumab, bevacizumab or aflibercept in patients with neovascular AMD (2014)
    Robert L. Avery, Alessandro Castellarin et al. British Journal of Ophthalmology
  2. Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: a randomized, perioperative phase 1 trial (2023)
    Ingo K. Mellinghoff, Min Lu et al. Nature Medicine

Citation Impact

68 standout
Sub-graph 1 of 23

Citing Papers

Age-Related Macular Degeneration
2024 Standout
Epigenetics-targeted drugs: current paradigms and future challenges
2024 Standout
6 intermediate papers

Works of Kha Le being referenced

Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: a randomized, perioperative phase 1 trial
2023 Standout
INDIGO: A global, randomized, double-blind, phase III study of vorasidenib (VOR; AG-881) vs placebo in patients (pts) with residual or recurrent grade II glioma with an isocitrate dehydrogenase 1/2 (IDH1/2) mutation.
2020
and 3 more

Author Peers

Author Molecular Biology Genetics Epidemiology Ophthalmology RNMI Last Decade Papers Cites
Kha Le 328 171 54 588 498 44 1.1k
Sebastián Neumeister 20 60
Rute Fernandes 85 4 13 3 21 9 460
Jared Stark 1 14 188
C. L. Suchman 12 1 2 9 506
Orkun Özener 16 1 23 711

All Works

Loading papers...

Rankless by CCL
2026